Painreform Ltd (PRFX) Stock Price, Quote & News

Company Profile

PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and pain treatment of hernia repair operatio...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 972 3 7177050

Website: www.painreform.com

Address:

65 Yigal Alon St., Tel Aviv, Israel

MuadDib1982 Jun. 16 at 6:44 PM

$PRFX i think this is going to get a pop. Been a few months since anything happened. All in.

1 · Reply

Weimanator Jun. 4 at 6:33 PM

$PRFX prepare for some news. Price action has started, if we don’t get a pop to 12.00 by end of year I will be very surprised

0 · Reply

Oooox Jun. 4 at 11:53 AM

$PRFX

0 · Reply

savaboy May. 27 at 3:09 AM

$PRFX We will see a $6 handle by end of month, promising pain medications and only $3M market cap. No resistance until $12

0 · Reply

krb102000 May. 9 at 1:42 AM

$PRFX does the chat work? Nobody is talking about why this low float POS isn’t moving up.

1 · Reply

max315 May. 8 at 1:48 PM

$PRFX anybody that's ever traded PRFX knows it ALWAYS comes back down to 1.8s

0 · Reply

TheRealShortSqueezy May. 8 at 1:41 PM

$PRFX Shorts in control today on small caps, this could see 1.68$ bottom from early April.

0 · Reply

TheRealShortSqueezy May. 8 at 1:37 PM

$PRFX Crap stock... I would of entered over those walls for 2.7-3$ pt but seems like the company is diluting here

0 · Reply

JL_TradeZ May. 8 at 1:22 PM

$WGRX $WGRX So where are all my haters at? 🤫 Like proving them wrong. Told y'all we would find a runner especially on the 8th day 😉 credits to @lemontree33 🤝 Day is just getting started baby 🔥🔥 $SCLX $WOLF $PRFX $KODK

0 · Reply

Bigmal1 May. 8 at 12:27 PM

$PRFX the sell off done?

1 · Reply

Blade Ranger: Consideration from PainReform Transaction Continues to Mature Following Growth in Software Sales

May 7, 2025, 4:30 PM EDT - 5 weeks ago

PainReform Launches Strategic AI Pilot with Econergy Using Its Proprietary DeepSolar™ Platform to Optimize One of Romania's Largest Solar Projects

Apr 10, 2025, 8:30 AM EDT - 2 months ago

PainReform Expands into Home Energy Management Sector, Leveraging DeepSolar's AI-Driven Platform to Address the Growing Solar Optimization Market

Apr 7, 2025, 5:00 PM EDT - 2 months ago

PainReform Provides Year-End Business Update

Mar 5, 2025, 11:00 AM EST - 3 months ago

PainReform Completes Strategic Acquisition of DeepSolar, Unlocking New Growth Opportunities in AI-Driven Solar Analytics

Feb 18, 2025, 8:30 AM EST - 4 months ago

PainReform Executes Definitive Agreement to Acquire DeepSolar, Marking a Unique Expansion Opportunity

Dec 27, 2024, 8:30 AM EST - 6 months ago

PainReform Provides Further Update on Phase 3 Clinical Trial of PRF-110

Nov 20, 2024, 8:30 AM EST - 7 months ago

PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial

Nov 7, 2024, 5:00 PM EST - 7 months ago

PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders' Equity Requirement

Sep 11, 2024, 8:30 AM EDT - 9 months ago

PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110

Sep 10, 2024, 9:46 AM EDT - 9 months ago

PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds

Aug 20, 2024, 8:30 AM EDT - 10 months ago

PainReform Announces Positive Safety Profile for PRF-110 in Phase 3 Bunionectomy Study

Aug 7, 2024, 10:00 AM EDT - 11 months ago

PainReform Announces Favorable Safety Profile of PRF-110, Indicating Potential for Use in New Surgical Applications Requiring Higher Doses

Aug 1, 2024, 8:30 AM EDT - 11 months ago

PainReform's New Manufacturing Process Achieves Significant Benefits Including 18-Month Stability of PRF-110 at Room Temperature

May 31, 2024, 4:15 PM EDT - 1 year ago

PainReform Announces Receipt of Nasdaq Minimum Bid Price Notification

May 15, 2024, 4:05 PM EDT - 1 year ago

PainReform Provides Business Update for the First Quarter of 2024

May 8, 2024, 8:30 AM EDT - 1 year ago

PainReform CEO Ilan Hadar Discusses Latest Developments Related to PRF-110 and its Potential to Help Tackle the Opioid Epidemic on Proactiveinvestors.com

Apr 18, 2024, 2:19 PM EDT - 1 year ago

PainReform Announces Closing of $4 Million Public Offering

Apr 9, 2024, 9:00 AM EDT - 1 year ago

PainReform's Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing Conditions

Apr 2, 2024, 8:30 AM EDT - 1 year ago

PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in Bunionectomy

Jan 22, 2024, 8:30 AM EST - 1 year ago

PainReform to Present at the Microcap Conference in Atlantic City

Jan 3, 2024, 8:30 AM EST - 1 year ago

PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain Relief

Dec 26, 2023, 6:00 PM EST - 1 year ago

PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross Proceeds

Nov 15, 2023, 4:05 PM EST - 1 year ago

PainReform Provides Business Update for the Third Quarter of 2023

Sep 11, 2023, 8:30 AM EDT - 1 year ago

PainReform Announces Plans to Commence Second Part of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgery Following Positive FDA Review of Drug Master File

Sep 7, 2023, 10:00 AM EDT - 1 year ago

PainReform Selected for Poster Presentation at the 13th Congress of the European Pain Federation in Budapest, Hungary

Sep 5, 2023, 8:30 AM EDT - 1 year ago

PainReform to Participate in the H.C. Wainwright 25th Annual Global Investment Conference in New York City

Aug 10, 2023, 4:05 PM EDT - 2 years ago

PainReform Provides Business Update for the Second Quarter of 2023

Jul 19, 2023, 9:00 AM EDT - 2 years ago

PainReform Regains Compliance with Nasdaq Continued Listing Requirements

Jul 14, 2023, 2:35 PM EDT - 2 years ago

PainReform Announces Pricing of $1.5 Million Concurrent Registered Direct Offering and Private Placement

Jul 12, 2023, 9:05 AM EDT - 2 years ago

PainReform Announces Pricing of $2.7 Million Concurrent Registered Direct Offering and Private Placement

Jun 15, 2023, 8:30 AM EDT - 2 years ago

PainReform to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 21st

Jun 7, 2023, 4:30 PM EDT - 2 years ago

PainReform Provides Regulatory Update on Second Part of its Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery

May 15, 2023, 4:45 PM EDT - 2 years ago

PainReform Provides Business Update for the First Quarter of 2023

May 1, 2023, 8:30 AM EDT - 2 years ago

PainReform Announces Positive Safety Data in First Part of Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery

Mar 28, 2023, 9:10 AM EDT - 2 years ago

PainReform Completes First Part of Phase 3 Clinical Trial in Patients Undergoing Bunionectomy Surgery

Mar 16, 2023, 8:00 AM EDT - 2 years ago

PainReform Provides Year-End Business Update; Commences Phase 3 Clinical Trial of PRF-110 in Bunionectomy

Feb 7, 2023, 4:05 PM EST - 2 years ago

PainReform Ltd. (NASDAQ: PRFX) Announces Receipt of Extension to Meet the Nasdaq's Minimum Bid Price Requirement

Nov 15, 2022, 8:30 AM EST - 2 years ago

PainReform Provides Business Update for the Third Quarter of 2022

Sep 1, 2022, 8:00 AM EDT - 3 years ago

PainReform to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Aug 16, 2022, 8:05 AM EDT - 3 years ago

PainReform Provides Business Update for the Second Quarter of 2022

Apr 12, 2022, 9:00 AM EDT - 3 years ago

PainReform to Present at The Noble Capital Markets' Eighteenth Annual Investor Conference on April 20th

Mar 21, 2022, 9:25 AM EDT - 3 years ago

PainReform to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th

Mar 17, 2022, 8:00 AM EDT - 3 years ago

PainReform Provides Year-End Business Update; on Track to Commence Phase 3 Trial of PRF-110 for Non-Opiate Post-Operative Pain Relief in the Second Half of 2022

Dec 14, 2021, 8:30 AM EST - 3 years ago

PainReform CEO to Participate in the Benzinga All Access Event on December 16th

Nov 16, 2021, 8:00 AM EST - 3 years ago

PainReform Provides Business Update for the Third Quarter of 2021

Oct 14, 2021, 8:30 AM EDT - 3 years ago

PainReform to Present at Dawson James Securities 6th Annual Small Cap Growth Conference on October 21, 2021

Aug 16, 2021, 8:00 AM EDT - 4 years ago

PainReform Provides Business Update for the Second Quarter of 2021

May 13, 2021, 8:15 AM EDT - 4 years ago

PainReform Provides Business Update for the First Quarter of 2021

Mar 18, 2021, 9:15 AM EDT - 4 years ago

PainReform Provides Year-End Business Update and Reports Progress Towards Commencing Phase 3 Trial of PRF-110 for Non-Opiate Post-Operative Pain Relief

MuadDib1982 Jun. 16 at 6:44 PM

$PRFX i think this is going to get a pop. Been a few months since anything happened. All in.

1 · Reply

Weimanator Jun. 4 at 6:33 PM

$PRFX prepare for some news. Price action has started, if we don’t get a pop to 12.00 by end of year I will be very surprised

0 · Reply

Oooox Jun. 4 at 11:53 AM

$PRFX

0 · Reply

savaboy May. 27 at 3:09 AM

$PRFX We will see a $6 handle by end of month, promising pain medications and only $3M market cap. No resistance until $12

0 · Reply

krb102000 May. 9 at 1:42 AM

$PRFX does the chat work? Nobody is talking about why this low float POS isn’t moving up.

1 · Reply

max315 May. 8 at 1:48 PM

$PRFX anybody that's ever traded PRFX knows it ALWAYS comes back down to 1.8s

0 · Reply

TheRealShortSqueezy May. 8 at 1:41 PM

$PRFX Shorts in control today on small caps, this could see 1.68$ bottom from early April.

0 · Reply

TheRealShortSqueezy May. 8 at 1:37 PM

$PRFX Crap stock... I would of entered over those walls for 2.7-3$ pt but seems like the company is diluting here

0 · Reply

JL_TradeZ May. 8 at 1:22 PM

0 · Reply

Bigmal1 May. 8 at 12:27 PM

$PRFX the sell off done?

1 · Reply

Tygalastkings187 May. 8 at 12:03 PM

$PRFX just popped to $2.80 somethings brewing 🚀💰

1 · Reply

popo12341 May. 8 at 11:35 AM

$PRFX $STI bought both at the lows for today

0 · Reply

E_Ross May. 8 at 11:32 AM

$PRFX 🚮

0 · Reply

TheRealShortSqueezy May. 8 at 11:31 AM

$PRFX Needs to clear the 100k wall here 2.48 to 2.52$

0 · Reply

rayankhader May. 8 at 11:14 AM

$PRFX adding here sl $2.10

0 · Reply

Thestocktraderhubzee May. 8 at 10:30 AM

WATCHLIST MAY 08 2025. $PRFX PainReform Launches Strategic AI Pilot With Econergy Renewable Energy; To Use Its PainReform's Proprietary DeepSolar Platform $DIS Needham Reiterates Buy on Walt Disney, Maintains $125 Price Target $JKS Jinko ESS Partners With SolarToday To Deliver SunGiga All-In-One Products Across Benelux, Romania, Greece, Germany, And Turkey $STI Solidion Unveils Patented Technology To Transform Lithium-Ion Facilities Into Solid-State Battery Producers $AOSL Alpha and Omega Semiconductor shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q4 sales guidance with its midpoint above estimates.

0 · Reply

JL_TradeZ May. 8 at 10:13 AM

$PRFX Float is super low at around 1.44M shares, which explains the sharp moves when volume hits. Short interest is pretty elevated too—roughly 17% of the float—so any squeeze pressure could really get things going.

0 · Reply

JL_TradeZ May. 8 at 9:44 AM

$PRFX Low float + hot PR = Can run nicely. Just need a to clear $2.5 with volume, this could get fun—watch those levels up to 2.70, 3, or even 4+ if buyers step in.

0 · Reply

JimBull May. 8 at 9:38 AM

$PRFX low float, news and warrants at higher price

0 · Reply

JL_TradeZ May. 8 at 9:30 AM

$PRFX Getting attention after news on an AI pilot with Econergy. Trading up premarket—watch for entry around 2.45 with room toward 2.7/3/3.5 and potentially $4+ if momentum holds. Stops under 2.30.

1 · Reply

Ric_1M May. 8 at 8:47 AM

$ASST $ZKIN $SEZL $PRFX $DEVS "Let us raise a standard to which the wise and honest can repair; the rest is in the hands of God." George Washington

0 · Reply

frankyboyz May. 8 at 8:35 AM

$PRFX 2.90 this far $PRFX off 2.4 dips baby

0 · Reply

Market Cap	3.74M
Revenue (ttm)	0.00
Net Income (ttm)	-14.59M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	33,400
Avg Vol	1,670,014
Day's Range	N/A - N/A
Shares Out	2.01M
Stochastic %K	1%
Beta	0.63
Analysts	Strong Buy
Price Target	$47.99